← Evidence map

ReviewCurrent rheumatology reports2020

Type I Interferonopathies: from a Novel Concept to Targeted Therapeutics.

Isabelle Melki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

23 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 32548765